Active — Not RecruitingNot Applicable

LAMBDA 002 (Lung Registry) Study

United States154 participantsStarted 2022-11-04

Plain-language summary

The LAMBDA 002 registry study is an observational, longitudinal, multi-center study observing patients undergoing lung transplant.

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Age 18 or older at the time of enrollment.
✓. Underwent a first single or bilateral deceased-donor lung transplant. 3) Allograft was from a genetically different donor (e.g., not an identical twin).

Percent of donor-derived cell-free DNA (ddcfDNA) measured via the Prospera test

Timeframe: 3 years

NCT IDNCT05170425

SponsorNatera, Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-08